期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 約2月

Journal of Drug Targeting publishes papers and reviews on all aspects of drug delivery and targeting for molecular and macromolecular drugs including the design and characterization of carrier systems (whether colloidal, protein or polymeric) for both vitro and/or in vivo applications of these drugs.

Papers are not restricted to drugs delivered by way of a carrier, but also include studies on molecular and macromolecular drugs that are designed to target specific cellular or extra-cellular molecules. As such the journal publishes results on the activity, delivery and targeting of therapeutic peptides/proteins and nucleic acids including genes/plasmid DNA, gene silencing nucleic acids (e.g. small interfering (si)RNA, antisense oligonucleotides, ribozymes, DNAzymes), as well as aptamers, mononucleotides and monoclonal antibodies and their conjugates. The diagnostic application of targeting technologies as well as targeted delivery of diagnostic and imaging agents also fall within the scope of the journal. In addition, papers are sought on self-regulating systems, systems responsive to their environment and to external stimuli and those that can produce programmed, pulsed and otherwise complex delivery patterns.

《藥物靶向雜志》發(fā)表有關(guān)分子和大分子藥物的藥物輸送和靶向的各個(gè)方面的論文和評(píng)論，包括這些藥物體外和/或體內(nèi)應(yīng)用的載體系統(tǒng)（無(wú)論是膠體、蛋白質(zhì)還是聚合物）的設(shè)計(jì)和特性。

論文不僅限于通過(guò)載體輸送的藥物，還包括旨在靶向特定細(xì)胞或細(xì)胞外分子的分子和大分子藥物的研究。因此，該雜志發(fā)表了關(guān)于治療性肽/蛋白質(zhì)和核酸（包括基因/質(zhì)粒 DNA、基因沉默核酸（例如小干擾 (si)RNA、反義寡核苷酸、核酶、DNA 酶）以及適體、單核苷酸和單克隆抗體及其結(jié)合物的活性、輸送和靶向性的結(jié)果。靶向技術(shù)的診斷應(yīng)用以及診斷和成像劑的靶向輸送也屬于該雜志的范圍。此外，我們還尋求有關(guān)自我調(diào)節(jié)系統(tǒng)、對(duì)環(huán)境和外部刺激有反應(yīng)的系統(tǒng)以及可以產(chǎn)生程序化、脈沖和其他復(fù)雜傳遞模式的系統(tǒng)的文章。

《Journal Of Drug Targeting》(藥物靶向雜志)編輯部通訊方式為TAYLOR & FRANCIS LTD, 4 PARK SQUARE, MILTON PARK, ABINGDON, ENGLAND, OXON, OX14 4RN。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。